Tirzepatide versus Semaglutide in the Risk of Cerebral Infarction in Patients with Diagnosis of Type 2 Diabetes Mellitus: A Propensity Score Matching from a Global Federated Health Network Analysis (S30.005)
This study aims to compare the risk of cerebral infarction between patients treated with Tirzepatide and those receiving Semaglutide, leveraging data from a Global Federated Health Network.
Authors
- Henrique Cal
- Sávio Batista
- Mariana Letícia de Bastos Maximiano (ORCID: https://orcid.org/0009-0005-8359-6763)
- Diogo Haddad Santos (ORCID: https://orcid.org/0000-0003-1474-1849)
- Henrique Cian da Cruz (ORCID: https://orcid.org/0000-0003-4216-0558)
Institutions
- Emory University (US)
- Universidade Federal Fluminense (BR)
- Centro Universitário Cesumar (BR)
- D’Or Institute for Research and Education (BR)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000212661
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00